The effect of vitamin A supplementation on postnatal adipose tissue development of lambs.
Vitamin A (retinoic acid) is known to be an adipogenic factor influencing both in vitro and in vivo cell development. This study aimed to determine its effect on lamb adipose tissue development during the early phase of postnatal development until 100 d of age. Male lambs (n = 24) of the Rasa Aragonesa breed were used. At birth, lambs were assigned to 1 of 2 experimental groups: 1) the control (C) group, which received feed without vitamin A supplementation, and 2) the vitamin A (V) group, which received a supplement of 500,000 IU/animal twice per week from birth to slaughter. The effect of vitamin A supplementation was studied at 16.8 +/- 0.35 kg of BW (58 +/- 0.7 d of age) and at 27.8 +/- 0.78 kg of BW (101 +/- 6.5 d of age). The variables of lamb growth, carcass, LM area, and lipid content were analyzed. To study adipose tissue development, the amount of adipose tissue accumulated, the size and number of adipocytes, and lipogenic enzyme activities (glycerol 3-phosphate dehydrogenase, fatty acid synthase, and glucose 6-phosphate dehydrogenase) of the omental, perirenal, and s.c. depots were quantified. Results showed that vitamin A supplementation had no influence on growth, carcass variables, LM area, and lipid content during lamb growth but that the number of adipocytes in the perirenal depot was 30% greater in lambs of the V group (P < 0.05) and that these lambs had smaller adipocytes in the omental and perirenal depots (P = 0.06) at 28 kg of BW (101 d of age). These results suggest that the intake of this level of vitamin A during the whole period of growth of the lambs influenced the processes of hyperplasia and hypertrophy in the different adipose depots, depending on their degree of maturity.
Arana
A
A
Escuela Técnica Superior de Ingenieros Agrónomos, Universidad Pública Navarra, Campus de Arrosadía, 31006 Pamplona, Spain.
Mendizabal
J A
JA
Alzón
M
M
Soret
B
B
Purroy
A
A
D017667:Adipocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D000273:Adipose Tissue / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development; D000818:Animals; D000831:Animals, Newborn; D001823:Body Composition; D048429:Cell Size / Q000187:drug effects; D019587:Dietary Supplements; D064429:Fatty Acid Synthases / Q000378:metabolism; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D005994:Glycerophosphates / Q000378:metabolism; D008297:Male; D011897:Random Allocation; D012756:Sheep / Q000254:growth & development*; D014801:Vitamin A / Q000097:blood / Q000494:pharmacology*; D014815:Vitamins / Q000494:pharmacology*
D005994:Glycerophosphates; D014815:Vitamins; D014801:Vitamin A; C029620:alpha-glycerophosphoric acid; D005954:Glucosephosphate Dehydrogenase; D064429:Fatty Acid Synthases